{
  "current_page": 367346,
  "docs": [
    {
      "code": "ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFPRINCIPALS_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: LongTermDebtMaturitiesRepaymentsOfPrincipals",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951752,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Long Term Debt Maturities Repayments Of Principals",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:03Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Long-Term-Debt-Maturities-Repayments-Of-Principals"
    },
    {
      "code": "ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFPRINCIPALS_Q",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: LongTermDebtMaturitiesRepaymentsOfPrincipals",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951751,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Long Term Debt Maturities Repayments Of Principals",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:16Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Long-Term-Debt-Maturities-Repayments-Of-Principals"
    },
    {
      "code": "ACRX_OPERATINGLEASESFUTUREMINIMUMPAYMENTS_Q",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: OperatingLeasesFutureMinimumPayments",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951753,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Operating Leases Future Minimum Payments",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Operating-Leases-Future-Minimum-Payments"
    },
    {
      "code": "ACRX_OPERATINGLEASESFUTUREMINIMUMPAYMENTS_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: OperatingLeasesFutureMinimumPayments",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951754,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Operating Leases Future Minimum Payments",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Operating-Leases-Future-Minimum-Payments"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDANDEXERCISABLEWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM_Q",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951755,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:03Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-And-Exercisable-Weighted-Average-Remaining-Contractual-Term"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDANDEXERCISABLEWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951756,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-And-Exercisable-Weighted-Average-Remaining-Contractual-Term"
    },
    {
      "code": "ACRX_EXPECTEDFUTUREINVESTMENT_Q",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ExpectedFutureInvestment",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951578,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Expected Future Investment",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2013-03-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Expected-Future-Investment"
    },
    {
      "code": "ACRX_EXPECTEDFUTUREINVESTMENT_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ExpectedFutureInvestment",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951757,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Expected Future Investment",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:04Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Expected-Future-Investment"
    },
    {
      "code": "ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFINTEREST_Q",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: LongTermDebtMaturitiesRepaymentsOfInterest",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951758,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Long Term Debt Maturities Repayments Of Interest",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Long-Term-Debt-Maturities-Repayments-Of-Interest"
    },
    {
      "code": "ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFINTEREST_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: LongTermDebtMaturitiesRepaymentsOfInterest",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951759,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Long Term Debt Maturities Repayments Of Interest",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:17Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Long-Term-Debt-Maturities-Repayments-Of-Interest"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSEXERCISESINPERIODTOTALINTRINSICVALUE_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951767,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:05Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Exercises-In-Period-Total-Intrinsic-Value"
    },
    {
      "code": "ACRX_OTHERNONCASHINCOMEEXPENSE_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: OtherNoncashIncomeExpense",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951766,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Other Noncash Income Expense",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:05Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Other-Noncash-Income-Expense"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSEXPECTEDDIVIDENDRATE_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951772,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:05Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Expected-Dividend-Rate"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSRISKFREEINTERESTRATEMINIMUM_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951774,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:19Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Risk-Free-Interest-Rate-Minimum"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSRISKFREEINTERESTRATEMAXIMUM_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951797,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:22Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Risk-Free-Interest-Rate-Maximum"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSGRANTSINPERIODWEIGHTEDAVERAGEGRANTDATEFAIRVALUE_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951803,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:22Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Grants-In-Period-Weighted-Average-Grant-Date-Fair-Value"
    },
    {
      "code": "ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDFAIRVALUE_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951804,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:23Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-Fair-Value"
    },
    {
      "code": "ACRX_CONTRIBUTIONSBYEMPLOYERTOPOSTEMPLOYMENTBENEFITOBLIGATIONS_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ContributionsByEmployerToPostemploymentBenefitObligations",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951808,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Contributions By Employer To Postemployment Benefit Obligations",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:23Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Contributions-By-Employer-To-Postemployment-Benefit-Obligations"
    },
    {
      "code": "ACRX_NETPROCEEDSFROMISSUANCEOFCOMMONSTOCK_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: NetProceedsFromIssuanceOfCommonStock",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951812,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Net Proceeds From Issuance Of Common Stock",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:23Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Net-Proceeds-From-Issuance-Of-Common-Stock"
    },
    {
      "code": "ACRX_PROCEEDSFROMISSUANCEOFCLASSCOMMONSTOCKNETOFISSUANCECOSTS_A",
      "column_names": [
        "Date",
        "Value"
      ],
      "description": "SEC Name: ProceedsFromIssuanceOfClassCommonStockNetOfIssuanceCosts",
      "display_url": null,
      "frequency": "daily",
      "from_date": "2012-12-31",
      "id": 9951813,
      "name": "ACELRX PHARMACEUTICALS INC  (ACRX): Annual Proceeds From Issuance Of Class Common Stock Net Of Issuance Costs",
      "private": false,
      "source_code": "SEC",
      "source_name": "U.S. Securities and Exchange Commission",
      "to_date": "2012-12-31",
      "type": null,
      "updated_at": "2014-02-19T01:44:23Z",
      "urlize_name": "ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Proceeds-From-Issuance-Of-Class-Common-Stock-Net-Of-Issuance-Costs"
    }
  ],
  "per_page": 20,
  "sources": [{
    "code": "SEC",
    "datasets_count": 4867,
    "description": "The Securities and Exchange commission is an agency of the United States government.\r\n\r\n\r\nTheir purpose is to regulate stock markets, and in doing so collect and distribute data on all publicly listed companies. ",
    "host": "www.sec.gov",
    "id": 651,
    "name": "U.S. Securities and Exchange Commission"
  }],
  "total_count": 10036987
}
